32 related articles for article (PubMed ID: 31746452)
1. Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play.
Satgunaseelan L; Sy J; Shivalingam B; Sim HW; Alexander KL; Buckland ME
Pathology; 2024 Mar; 56(2):158-169. PubMed ID: 38233331
[TBL] [Abstract][Full Text] [Related]
2. Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics.
Śledzińska P; Bebyn M; Szczerba E; Furtak J; Harat M; Olszewska N; Kamińska K; Kowalewski J; Lewandowska MA
Mol Diagn Ther; 2022 Nov; 26(6):699-713. PubMed ID: 36053463
[TBL] [Abstract][Full Text] [Related]
3. Indicators of correct targeting in stereotactic biopsy of intracranial lesions.
Vilela-Filho O; Porfírio J; Goulart LC
Surg Neurol Int; 2022; 13():251. PubMed ID: 35855128
[TBL] [Abstract][Full Text] [Related]
4. Infratentorial Stereotactic Biopsy of Brainstem and Cerebellar Lesions.
Furtak J; Śledzińska P; Bebyn MG; Szylberg T; Krajewski S; Birski M; Harat M
Brain Sci; 2021 Oct; 11(11):. PubMed ID: 34827431
[TBL] [Abstract][Full Text] [Related]
5. Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation.
Brito C; Azevedo A; Esteves S; Marques AR; Martins C; Costa I; Mafra M; Bravo Marques JM; Roque L; Pojo M
BMC Cancer; 2019 Oct; 19(1):968. PubMed ID: 31623593
[TBL] [Abstract][Full Text] [Related]
6. Assessment of molecular markers demonstrates concordance between samples acquired via stereotactic biopsy and open craniotomy in both anaplastic astrocytomas and glioblastomas.
Gessler F; Baumgarten P; Bernstock JD; Harter P; Lescher S; Senft C; Seifert V; Marquardt G; Weise L
J Neurooncol; 2017 Jun; 133(2):399-407. PubMed ID: 28508327
[TBL] [Abstract][Full Text] [Related]
7. Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial.
Wiestler B; Capper D; Hovestadt V; Sill M; Jones DT; Hartmann C; Felsberg J; Platten M; Feiden W; Keyvani K; Pfister SM; Wiestler OD; Meyermann R; Reifenberger G; Pietsch T; von Deimling A; Weller M; Wick W
Neuro Oncol; 2014 Dec; 16(12):1630-8. PubMed ID: 25028501
[TBL] [Abstract][Full Text] [Related]
8. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF
Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548
[TBL] [Abstract][Full Text] [Related]
9. RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.
Chen SC; Lo CM; Wang SH; Su EC
BMC Bioinformatics; 2019 Dec; 20(Suppl 19):659. PubMed ID: 31870275
[TBL] [Abstract][Full Text] [Related]
10. Biomarker concordance between molecular stereotactic biopsy and open surgical specimens in gliomas.
Furtak J; Mielczarek M; Szylberg M; Harat M
Neurol Neurochir Pol; 2019; 53(6):435-441. PubMed ID: 31746452
[TBL] [Abstract][Full Text] [Related]
11. Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.
Weller M; Stupp R; Hegi ME; van den Bent M; Tonn JC; Sanson M; Wick W; Reifenberger G
Neuro Oncol; 2012 Sep; 14 Suppl 4(Suppl 4):iv100-8. PubMed ID: 23095825
[TBL] [Abstract][Full Text] [Related]
12. Predictive biomarkers in adult gliomas: the present and the future.
Thomas L; Di Stefano AL; Ducray F
Curr Opin Oncol; 2013 Nov; 25(6):689-94. PubMed ID: 24076583
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
